- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00213863
Implantation of Porous Titanium Prosthesis in Laryngeal Surgery
June 28, 2012 updated by: University Hospital, Strasbourg, France
This study evaluates a medialization implant to treat vocal cord paralysis, to permit it to adjust the quality of the voice under local or general anesthesia.
The aim is to restore phonation using a porous titanium prosthesis in laryngeal surgery.
Study Overview
Status
Unknown
Conditions
Study Type
Interventional
Enrollment (Anticipated)
10
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Christian Debry, MD
- Email: christian.debry@chru-strasbourg.fr
Study Locations
-
-
-
Strasbourg, France
- Recruiting
- Service d'Oto-Rhino-Laryngologie et de Chirurgie Cervico-Faciale, Hôpital de Hautepierre
-
Sub-Investigator:
- Philippe SCHULTZ, MD
-
Principal Investigator:
- Christian DEBRY, MD
-
Contact:
- Christian Debry, MD
- Phone Number: 33.3.88.12.76.45
- Email: christian.debry@chru-strasbourg.fr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Males or females greater than 18 years old
Exclusion Criteria:
- Age less than 18 years
- Pregnant women
- Local carcinoma excluding radiotherapeutic or surgical control
- Bad general condition
- Contraindication to general anesthesia
- Non-controlled diabetes
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Nasofibroscopy
Time Frame: 8 days and 3 months after surgery
|
8 days and 3 months after surgery
|
Voice control and recording
Time Frame: 8, 15, 30 days, 3, 6 months after surgery and then, every 6 months during the whole trial
|
8, 15, 30 days, 3, 6 months after surgery and then, every 6 months during the whole trial
|
All types of complication
Time Frame: 8, 15, 30 days, 3, 6 months after surgery and then, every 6 months during the whole trial
|
8, 15, 30 days, 3, 6 months after surgery and then, every 6 months during the whole trial
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Christian DEBRY, MD, Hopitaux Universitaires de Strasbourg
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2010
Primary Completion (Anticipated)
May 1, 2016
Study Completion (Anticipated)
November 1, 2016
Study Registration Dates
First Submitted
September 13, 2005
First Submitted That Met QC Criteria
September 13, 2005
First Posted (Estimate)
September 21, 2005
Study Record Updates
Last Update Posted (Estimate)
July 2, 2012
Last Update Submitted That Met QC Criteria
June 28, 2012
Last Verified
June 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 3097
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vocal Cord Paralysis
-
University of ManitobaCompletedVocal Cord Paresis | Acquired Vocal Cord PalsyCanada
-
Pak Emirates Military HospitalCompletedParalysis of Vocal Cords or Larynx | Bilateral Vocal Cord ParalysisPakistan
-
University of FloridaCompletedUnilateral Vocal Cord Paralysis | Unilateral Vocal Cord ParesisUnited States
-
Sofregen Medical, Inc.CompletedVocal Cord Paralysis | Vocal Cord Atrophy | Vocal Fold PalsyUnited States
-
APrevent Biotech GmbHCompletedParalysis, Unilateral, Vocal CordAustria
-
Chang Gung Memorial HospitalUnknownUnilateral Vocal Cord ParalysisTaiwan
-
Chang Gung Memorial HospitalUnknownUnilateral Vocal Cord ParalysisTaiwan
-
Chang Gung Memorial HospitalNational Science Council, TaiwanCompletedParalysis, Unilateral, Vocal CordTaiwan
-
MED-EL Elektromedizinische Geräte GesmbHRecruitingBilateral Vocal Cord ParalysisAustria, Germany
-
Cliniques universitaires Saint-Luc- Université...Active, not recruitingUnilateral Vocal Cord ParalysisBelgium